“Drug-resistant infections presents one of the biggest threats to our future global health and economic security. Successfully addressing the rise in drug-resistant infections hinges on obtaining and using reliable and openly accessible surveillance data."

"Industry, patients and healthcare workers can all benefit from this which is why I encourage all industry to contribute to the register. I hope that we can all play our parts to support the Vivli platform in any way we can."

“One of things that we have learned is the importance of sharing data and open data, now COVID has shown that it is do-able and that sharing data actually achieves real results."